Does an elevated broad urinary mycotoxin panel indicate exposure to multiple mycotoxin classes?

Urinary testing using multi-analyte panels offers a highly sensitive method to evaluate complex exposure profiles. While a broad urinary pattern indicates the presence of multiple mycotoxins, interpreting these findings clinically requires distinguishing between environmental and dietary sources.

Analytical detection of multi-class exposures

• High sensitivity and specificity: Liquid chromatography-tandem mass spectrometry (LC-MS/MS) provides robust analytical detection of ochratoxin A, aflatoxin B2, fumonisin B1, diacetoxyscirpenol, verrucarin A, and verrucarin J in human urine.
• Broad exposure profile: Concurrent elevations of these compounds confirm the internal presence of multiple distinct chemical classes. This pattern reflects genuine multi-class exposure rather than an isolated analytical anomaly or single-marker error.

Dietary confounding and clinical limitations

• Primary dietary source: Dietary ingestion is the primary and ubiquitous source of urinary mycotoxins in the general population.
• Ubiquity in food: Common foods like grains and cereals routinely lead to detectable urinary excretion of these toxins in healthy individuals, heavily confounding attempts to attribute these markers to environmental inhalational exposure from water-damaged buildings.
• Lack of diagnostic specificity: A positive multi-class panel lacks the clinical specificity required to differentiate foodborne ingestion from environmental inhalation.
• Absence of clinical standards: There are currently no validated clinical reference ranges or FDA-approved diagnostics linking specific urinary concentrations to environmental mold illness.

Bottom line

• An elevated broad multi-analyte urinary panel plausibly confirms exposure to multiple mycotoxin classes, but it lacks the clinical specificity to differentiate common dietary ingestion from environmental mold exposure.